Caval Valve Implantation (CAVI): An Emerging Therapy for Treating Severe Tricuspid Regurgitation

Severe tricuspid regurgitation remains a challenging heart-valve disease to effectively treat with high morbidity and mortality at mid-term. Currently guideline-directed medical treatment is limited to escalating dose of diuretics, and the rationale and timing of open-heart surgery remains controver...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdul-Jawad Altisent, Omar, Benetis, Rimantas, Rumbinaite, Egle, Mizarien, Vaida, Codina, Pau, Gual-Capllonch, Francisco, Spitaleri, Giosafat, Fernandez-Nofrerias, Eduard, Bayes-Genis, Antoni, Puri, Rishi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509289/
https://www.ncbi.nlm.nih.gov/pubmed/34640619
http://dx.doi.org/10.3390/jcm10194601

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509289/
https://www.ncbi.nlm.nih.gov/pubmed/34640619
http://dx.doi.org/10.3390/jcm10194601

Ejemplares similares